new oral antiviral for chronic hepatitis B called Baraclude (entecavir)

Health Canada has approved a new oral antiviral for chronic hepatitis B called Baraclude (entecavir).

It will be used as an alternative to Intron A (interferon alfa-2b)...Heptovir (lamivudine)...or Hepsera (adefovir).

Intron A is effective for suppressing the hepatitis B virus and requires a shorter treatment duration than the oral antivirals.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote